Pregabalin for the management of partial epilepsy

References

• ArroyoSAnhutHKuglerAR2004Pregabalin add-on treatment: a randomized double-blind placebo-controlled dose-response study in adults with partial seizuresEpilepsia4520714692903
   PubMed Web of Science ®Google Scholar
• BandelowBWedekindDLeonT2007Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic interventionExpert Rev Neurother77698117610384
   PubMedGoogle Scholar
• Ben-MenachemE2004Pregabalin pharmacology and its relevance to clinical practiceEpilepsia45Suppl 613815315511
   PubMed Web of Science ®Google Scholar
• BeydounAUthmanBMKuglerAR2005Safety and efficacy of two pregabalin regimens for partial epilepsy: an add-on, placebo-controlled trialNeurology644758015699378
   PubMed Web of Science ®Google Scholar
• BeydounANasreddineWAtwehS2008Efficacy and tolerability of pregabalin in partial epilepsyExpert Rev Neurother810132418590472
   PubMedGoogle Scholar
• BlommelMLBlommelAL2007Pregabalin: an antiepileptic agent useful for neuropathic painAm J Health Syst Pharm6414758217617497
   PubMed Web of Science ®Google Scholar
• BockbraderHNMillerRFrameB2005The concomitant use of pregabalin and oral contraceptives does not affect the efficacy of either agentEpilepsia46Suppl 8170
   Google Scholar
• BriggsDELeeCMSpiegelK2008Reduction of secondarily generalized tonic-clonic (SGTC) seizures with pregabalinEpilepsy Res [Epub ahead of print]
   Web of Science ®Google Scholar
• BrodieMJ2004Pregabalin as adjunctive therapy for partial seizuresEpilepsia45Suppl 6192715315512
   PubMed Web of Science ®Google Scholar
• BrodieMJWilsonEAWescheDA2005Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, andvalproate in patients with partial epilepsyEpilepsia4614071316146435
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products (CPMP)2000Note for guidance on clinical investigation of medicinal products in the treatment of epileptic disorders. CPMP/EWP/566/98rev1. LondonAccessed on 25 August 2006 URL: www.emea.eu.int/pdfs/human/ewp/056698en.pdf
   Google Scholar
• CramerJAFisherRBen-MenachemE1999New antiepileptic drugs: comparison of key clinical trialsEpilepsia4059060010386528
   PubMed Web of Science ®Google Scholar
• CundyKCSastrySLuoW2008Clinical pharmacokinetics of XP13512, a novel transported prodrug of GabapentinJ Clin Pharmacol930 Epub ahead of print
   Web of Science ®Google Scholar
• DooleyDJDonovanCMMederWP2002Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slicesSynapse451719012112396
   PubMed Web of Science ®Google Scholar
• ElgerCEBrodieMJAnhutH2005Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled studyEpilepsia4619263616393158
   PubMed Web of Science ®Google Scholar
• ErranteLDPetroffOA2002Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrationsSeizure12300612810343
   PubMed Web of Science ®Google Scholar
• FengMRTurluckDBurleighJ2001Brain microdialysis and PK/PD correlation of pregabalin in ratsEur J Drug Metab Pharmacokinet26123811554426
   PubMed Web of Science ®Google Scholar
• FerrendelliJA2001Concerns with antiepileptic drug initiation: safety, tolerability, and efficacyEpilepsia42Suppl 4283011564122
   PubMed Web of Science ®Google Scholar
• FinkKDooleyDJMederWP2002Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortexNeuropharmacology422293611804619
   PubMed Web of Science ®Google Scholar
• FramptonJEScottLJ2004Pregabalin: in the treatment of painful diabetic peripheral neuropathyDrugs6428132015563250
   PubMed Web of Science ®Google Scholar
• FreemanRDurso-DecruzEEmirB2008Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of dosesDiabetes Care3114485418356405
   PubMed Web of Science ®Google Scholar
• FrenchJArrigoC2005Rapid onset of action of levetiracetam in refractory epilepsy patientsEpilepsia46324615679515
   PubMed Web of Science ®Google Scholar
• FrenchJAKuglerARRobbinsJL2003Dose-response trial of pregabalin adjunctive therapy in patients with partial seizuresNeurology601631712771254
   PubMed Web of Science ®Google Scholar
• GazzolaDMBalcerLJFrenchJA2007Seizure-free outcome in randomized add-on trials of the new antiepileptic drugsEpilepsia481303717521343
   PubMed Web of Science ®Google Scholar
• HellwigSAmtageF2008Pregabalin-induced cortical negative myoclonus in a patient with neuropathic painEpilepsy Behav134182018492617
   PubMed Web of Science ®Google Scholar
• HitirisNBarrettJABrodieMJ2006Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reportsEpilepsy Behav84182116446121
   PubMed Web of Science ®Google Scholar
• HoppeCRademacherMHoffmannJM2008Bodyweight gain under pregabalin therapy in epilepsy: Mitigation by counseling patients?Seizure173273218060813
   PubMed Web of Science ®Google Scholar
• HuppertzHJFeuersteinTJSchulze-BonhageA2001Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalinEpilepsia42790211422338
   PubMed Web of Science ®Google Scholar
• Janiczek-DolphinNCorriganBWBockbraderHN2005Diuretics, oral hypoglycemic agents, and insulin do not alter pregabalin pharmacokineticsEpilepsia46Suppl 6115
   Google Scholar
• JezykNLiCStewartBH1999Transport of pregabalin in rat intestine and Caco-2 monolayersPharm Res165192610227706
   PubMed Web of Science ®Google Scholar
• KälviäinenRKhyuppenenJKoskenkorvaP2008Clinical picture of EPM1-Unverricht-Lundborg diseaseEpilepsia495495618325013
   PubMed Web of Science ®Google Scholar
• LeppikIDe RueKEdrichP2006Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experienceEpileptic Disord81183016793573
   PubMed Web of Science ®Google Scholar
• LiZDonevanSTaylor2005High-affinity binding of pregabalin at alpha-2-delta subunits of voltage-gated calcium channel: Contribution to anticonvulsant actionEpilepsia46Suppl 628015679509
   PubMed Web of Science ®Google Scholar
• LozsadiDHemmingKMarsonAG2008Pregabalin add-on for drug-resistant partial epilepsyCochrane Database Syst Rev1CD00561218254084
   PubMed Web of Science ®Google Scholar
• MálagaISanmartiFX2006Two cases of painful gynecomastia and lower extremity pain in association with pregabalin therapyEpilepsia471576916981876
   PubMed Web of Science ®Google Scholar
• MayTRambeckBNebR2007Serum concentrations of pregabalin in patients with epilepsy: The influence of dose, age, and comedicationTher Drug Monit297899418043477
   PubMed Web of Science ®Google Scholar
• McLeanMJ1994Clinical pharmacokinetics of gabapentinNeurology44Suppl 5S17228022536
   PubMed Web of Science ®Google Scholar
• ModurPNMilteerWE2008Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsyEpilepsy Behav13554618579443
   PubMed Web of Science ®Google Scholar
• MohanrajRBrodieMJ2003Measuring the efficacy of antiepileptic drugsSeizure124134312967570
   PubMed Web of Science ®Google Scholar
• OwenRT2007Pregabalin: its efficacy, safety and tolerability profile in generalized anxietyDrugs Today436011017940637
   PubMed Web of Science ®Google Scholar
• PeruccaE2002What can we learn from clinical trials of anticonvulsant drugs in epilepsy?Eur J Pain6Suppl A354411888239
   PubMed Web of Science ®Google Scholar
• PeruccaE2006Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of ageClin Pharmacokinet453516316584283
   PubMed Web of Science ®Google Scholar
• PeruccaE2008Designing clinical trials to assess antiepileptic drugs as monotherapy: difficulties and solutionsCNS Drugs229173818840033
   PubMed Web of Science ®Google Scholar
• PeruccaERobbinsJLKugler2002Pregabalin demonstrates anticonvulsant activity onset by the second dayEpilepsia43Suppl 848
   Google Scholar
• PiyapolrungrojNLiCBockbraderH2001Mucosal uptake of gabapentin (neurontin) vs. pregabalin in the small intestinePharm Res1811263011587483
   PubMed Web of Science ®Google Scholar
• RandinitisEJPosvarELAlveyCW2003Pharmacokinetics of pregabalin in subjects with various degrees of renal functionJ Clin Pharmacol432778312638396
   PubMed Web of Science ®Google Scholar
• RheimsSCucheratMArzimanoglouA2008Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsyPLoS Med5e166122336
   Google Scholar
• RyvlinP2005Defining success in clinical trials – profiling pregabalin, the newest AEDEur J NeurolSuppl 4122116144536
   PubMed Web of Science ®Google Scholar
• RyvlinPRheimsSSemahF2006Meta-Analysis of add-on treatment in drug resistant partial epilepsy: a comprehensive study of 41 randomized controlled trials among 10 AEDsNeurology66Suppl 2A36
   Google Scholar
• ShnekerBFMcAuleyJW2005Pregabalin: a new neuromodulator with broad therapeutic indicationsAnn Pharmacother3920293716288079
   PubMed Web of Science ®Google Scholar
• TassoneDMBoyceEGuyerJ2007Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disordersClin Ther29264817379045
   PubMed Web of Science ®Google Scholar
• TaylorCPVartanianMG1997Profile of the anticonvulsant activity of CI-1008 (pregabalin) in animal modelsEpilepsia38Suppl 88
   Google Scholar
• VartanianMGRadulovicLLKinsoraJJ2006Activity profile of pregabalin French JA (2001). Proof of efficacy trials: endpointsEpilepsy Res45536
   Google Scholar
• WalkerMCSanderJW1996The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goalNeurology4691248780062
   PubMed Web of Science ®Google Scholar
• WarnerGFiggitDP2005Pregabalin as adjunctive treatment of partial seizuresCNS Drugs192657215740180
   PubMed Web of Science ®Google Scholar